Strides Pharma Board of Directors to Host Fundraiser Feb. 10



Strides Pharma Science announced on Monday that the company’s board of directors will meet on February 10, 2022 to consider raising funds.

In an exchange filing, the company said the board would consider a proposal to raise funds on Feb. 10 through the issuance of convertible stock/warrants and/or any other instrument through preferential issuance on a private placement basis, subject to such regulatory or statutory approvals.

On the same day, the company will announce its financial results for the three and nine months ended December 31, 2021.



Shares of Strides Pharma were trading up 0.63% at Rs 392.05 on BSE.

Strides Pharma Science is a global pharmaceutical company. The company operates primarily in regulated markets and has an “in Africa for Africa” strategy as well as an institutional business to serve donor-funded markets. The company focuses on hard-to-manufacture products that are sold in over 100 countries.

The company reported a consolidated net loss of Rs 162.55 crore in Q2 FY22 against a net profit of Rs 80.94 crore in Q2 FY21. Operating revenue during the quarter fell by 9.08% year-on-year to Rs 721.47 crore.

Powered by Capital Market – Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor

Previous Bankruptcy watchdog challenges legal shield in Boy Scouts abuse deal
Next Australia's AMP sees profit surge as fund management unit receives 'inquiries'